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Clusterin is an extracellular chaperone that specifically interacts with slowly
aggregating proteins on their off-folding pathway
Abstract
Clusterin is an extracellular mammalian chaperone protein which inhibits stress-induced precipitation of
many different proteins. The conformational state(s) of proteins that interact with clusterin and the
stage(s) along the folding and off-folding (precipitation-bound) pathways where this interaction occurs
were previously unknown. We investigated this by examining the interactions of clusterin with different
structural forms of α-lactalbumin, γ-crystallin and lysozyme. When assessed by ELISA and native gel
electrophoresis, clusterin did not bind to various stable, intermediately folded states of α-lactalbumin nor
to the native form of this protein, but did bind to and inhibit the slow precipitation of reduced αlactalbumin. Reduction-induced changes in the conformation of α-lactalbumin, in the absence and
presence of clusterin, were monitored by real-time 1H NMR spectroscopy. In the absence of clusterin, an
intermediately folded form of α-lactalbumin, with some secondary structure but lacking tertiary structure,
aggregated and precipitated. In the presence of clusterin, this form of α-lactalbumin was stabilised in a
non-aggregated state, possibly via transient interactions with clusterin prior to complexation. Additional
experiments demonstrated that clusterin potently inhibited the slow precipitation, but did not inhibit the
rapid precipitation, of lysozyme and γ-crystallin induced by different stresses. These results suggest that
clusterin interacts with and stabilises slowly aggregating proteins but is unable to stabilise rapidly
aggregating proteins. Collectively, our results suggest that during its chaperone action, clusterin
preferentially recognises partly folded protein intermediates that are slowly aggregating whilst venturing
along their irreversible off-folding pathway towards a precipitated protein.
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ABSTRACT

Clusterin is an extracellular mammalian chaperone protein which inhibits stressinduced precipitation of many different proteins. The conformational state(s) of
proteins that interact with clusterin and the stage(s) along the folding and off-folding
(precipitation-bound) pathways where this interaction occurs were previously
unknown. We investigated this by examining the interactions of clusterin with a
variety of different structural forms of -lactalbumin, -crystallin and lysozyme.
When assessed by ELISA and native gel electrophoresis, clusterin did not bind to
various stable, intermediately folded states of -lactalbumin nor to the native form of
this protein, but did bind to and inhibit the slow precipitation of reduced lactalbumin. Reduction-induced changes in the conformation of -lactalbumin, in the
absence and presence of clusterin, were monitored by real-time
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H NMR

spectroscopy. In the absence of clusterin, an intermediately folded form of lactalbumin, with some secondary structure but lacking tertiary structure, aggregated
and precipitated. In the presence of clusterin, this form of -lactalbumin was
stabilised in a non-aggregated state, possibly via transient interactions with clusterin
prior to complexation. Additional experiments demonstrated that clusterin potently
inhibited the slow precipitation, but did not inhibit the rapid precipitation, of
lysozyme and -crystallin induced by different stresses. These results suggest that
clusterin interacts with and stabilises slowly aggregating proteins but is unable to
stabilise rapidly aggregating proteins. Collectively, our results suggest that during its
chaperone action, clusterin preferentially recognises partly folded protein
intermediates that are slowly aggregating whilst venturing along their irreversible offfolding pathway towards a precipitated protein.

Keywords
Molecular chaperone; Protein unfolding; Aggregation; Clusterin; Small heat-shock
proteins
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Abbreviations
3SS--lactalbumin: -lactalbumin with Cys6-Cys120 selectively reduced and
carboxymethylated; DTT: dithiothreitol; GuHCl: guanidinium hydrochloride; HDC:
1% heat-denatured casein dissolved in PBS; HMW: high-molecular-weight; PBS:
phosphate-buffered saline; R-cam--lactalbumin: reduced and carboxyamidated lactalbumin; R-cm--lactalbumin: reduced and carboxymethylated -lactalbumin;
sHsp: small heat-shock protein.

1. INTRODUCTION

Molecular chaperones are a diverse group of proteins that interact with unfolded or
partly folded proteins to stabilise them, thereby preventing them from potentially
aggregating and precipitating [1,2]. Molecular chaperones are involved in a variety of
cellular tasks including protein folding, trafficking and general stabilisation. As a
result of their stabilising ability, the expression of many molecular chaperones is
upregulated in disease states that are associated with protein misfolding and
precipitation, for example, Alzheimer’s, Creutzfeldt-Jakob and Parkinson’s diseases
[3]. Intracellularly, the well-characterised chaperone proteins, Hsp40, Hsp60 and
Hsp70 (DnaJ, GroEL and DnaK in E. coli), are intimately involved in regulating the
correct folding of some proteins in the crowded environment of the cell [4]. Another
class of intracellular molecular chaperones, the small heat-shock proteins (sHsps), are
not directly involved in protein folding. Instead, they are the major proteins
associated with stabilising other proteins under stress conditions (e.g. heat, oxidation,
infection, etc.) to prevent their large-scale precipitation [5]. In this process, the partly
folded, stressed protein interacts via predominantly hydrophobic interactions with the
sHsp to form a complex. Subsequently, when cellular conditions return to normal,
this protein may be refolded via interaction with Hsp70 coupled to ATP hydrolysis
[5,6]. Thus, the expression of sHsps and Hsp70 is significantly increased under stress
conditions [5].
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Recently, we described the sHsp-like chaperone ability of the ubiquitous extracellular
mammalian protein, clusterin [7]. Our data indicate that clusterin shares many
similarities with sHsps in its mode of interaction with stressed proteins: it is a very
efficient chaperone; it forms, primarily via hydrophobic interactions, complexes (of
high mass) with stressed proteins; and it has no inherent ability to refold stressed
proteins after the removal of stress [7-9, unpublished data]. Furthermore, as has been
shown for some of the sHSPs [5,6], we have demonstrated that stressed proteins
complexed with clusterin are stabilised in a folding-competent state that can readily
be recovered into a correctly folded form via an ATP-dependent interaction with
Hsp70 [9]. The implication from this observation is that the stressed protein is bound
to clusterin in a partly folded state that is readily accessible to molecular chaperones
with refolding ability.

Following synthesis, proteins traverse rapidly along their folding pathway from
unfolded to folded (and hence active) conformations. In between these two extremes,
proteins adopt a variety of partly folded intermediates or molten globule states (e.g.
designated I1 and I2) with varying degrees of structure. Along this pathway, molecular
chaperones such as Hsp40, Hsp60 and Hsp70 assist the folding of proteins into their
correct conformation. The protein folding pathway is reversible and, under stress
conditions, proteins unfold from their native conformation along the reverse of this
pathway to adopt intermediately folded states. Being partly structured, these
intermediates expose significant hydrophobicity to solution. It is then possible for
them to deviate from the folding/unfolding pathway along an irreversible off-folding
pathway, leading to aggregation and potentially precipitation. sHsps interact with
proteins along this pathway [10,11]. The conformational state(s) of proteins that
interact with clusterin and the stage(s) along these pathways where this interaction
occurs were previously unknown. We used an approach similar to that taken with the
sHsps [10] to investigate this by examining the interactions of clusterin with a variety
of structured forms of -lactalbumin, -crystallin and lysozyme.
-Lactalbumin is a small, monomeric milk protein (mass ~14 kDa) that has a bound
calcium ion at the interface between its two domains [12]. It is possible to prepare
chemically-modified, monomeric and stable states of -lactalbumin with varying
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degrees of partly folded structure that have structural similarities to intermediates
along the folding/unfolding pathway of -lactalbumin (Table 1) [13,14]. GroEL
interacts with some of these stable -lactalbumin intermediates [15,16] but crystallin, a representative sHsp, does not [10]. The folding/unfolding pathway of lactalbumin, and the intermediates along it, have been well characterised [17].
Reduction of the four disulphide bonds of -lactalbumin with dithiothreitol (DTT)
also leads to a partly structured intermediate (Table 1). However, this intermediate
has significant exposed hydrophobicity and slowly aggregates and precipitates along
the off-folding pathway [10,11]. -Lactalbumin is an extracellular protein and is
therefore a potential protein target for clusterin during its chaperone action in vivo
under stress conditions. Reduction is not a physiologically relevant extracellular
stress in vivo. However, since the structures of -lactalbumin intermediates are well
studied and understood, conclusions drawn from studies of their interactions with
clusterin have implications for defining the conformational features of stressed
proteins that act as chaperone substrates for clusterin in vivo.
In this study, the interaction of clusterin with intermediately folded forms of lactalbumin was examined by ELISA, native gel electrophoresis and real-time 1H
NMR spectroscopy. In addition, the interaction of clusterin with both slowly and
rapidly precipitating forms of -crystallin and lysozyme was investigated. Overall, the
results indicate that clusterin is like the sHsps in recognising only slowly aggregating,
precipitation-bound forms of stressed proteins on an off-folding pathway.
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2. EXPERIMENTAL

Reagents
Bovine -lactalbumin (calcium-depleted), lysozyme, bovine serum albumin,
ovotransferrin and dithiothreitol (DTT) were purchased from Sigma (Sydney,
Australia). Deuterated 1,4-D,L-d10-DTT was obtained from Cambridge Isotopes
Laboratories (MA, USA). -Crystallin was purified from bovine lenses by size
exclusion chromatography using standard methods [18]. Three stable, partly folded
derivatives of -lactalbumin were prepared by methods described in [13,14]: R-cam-lactalbumin with its four disulphide bonds reduced and subsequently blocked by
carboxyamidation, R-cm--lactalbumin with its four disulphide bonds reduced and
subsequently blocked by carboxymethylation, and 3SS--lactalbumin with Cys6Cys120 selectively reduced and blocked by carboxymethylation. Their correct masses
were confirmed by electrospray ionisation mass spectrometry. Apo -lactalbumin
was prepared by heating solutions of the native protein, containing 1.5 mM EDTA,
for 1 h at 45 oC. Clusterin was prepared from human serum using immunoaffinity
chromatography as described earlier [19]. Clusterin-specific monoclonal antibodies,
G7, 41D and 78E, were as described [20]. Agarose was obtained from Promega
(Sydney, Australia). All other chemicals were of reagent grade and were obtained
from Ajax Chemicals (Sydney, Australia).

ELISA
The -lactalbumin derivatives (R-cam--lactalbumin, R-cm--lactalbumin, 3SS-lactalbumin) at 1 mg/ml in 20 mM NaH2PO4, pH 7.2, were adsorbed onto ELISA
trays for 1 h at 37 °C (45 °C for apo -lactalbumin). Native -lactalbumin was
adsorbed to ELISA trays at 1 mg/ml in 20 mM NaH2PO4, pH 7.2, for 5 h at 37 °C. Lactalbumin was also adsorbed to ELISA trays during reduction-induced aggregation
by incubating the protein (at 1 mg/ml) in 20 mM NaH2PO4, 0.1 M NaCl, pH 7.2,
containing 20 mM DTT, in ELISA wells for 5 h at 37 oC. Lyzozyme (50 g/ml in 0.1
M NaHCO3, pH 9.5) was adsorbed for 1 h at 37 °C and then reduced by incubation
with 15 mM DTT in PBS for 1 h at 37 °C. Following these steps, the ELISA trays
were blocked for 1 h at 37 °C with HDC (10 mM phosphate, 150 mM NaCl, 1%
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(w/v) heat-denatured casein, 0.04% (w/v) thymol, pH 7.4). Subsequently, purified
clusterin dissolved in HDC (at 10 g/ml or at concentrations indicated in Figures)
was incubated in ELISA wells for 1 h at 37 oC. The wells were then repeatedly
washed with PBS and clusterin bound to the adsorbed proteins was measured using
(i) an equi-volume mixture of G7, 41D and 78E monoclonal antibody tissue culture
supernatants, followed by (ii) horseradish peroxidase-conjugated sheep anti-mouse Ig
antibody, as described previously [7]. The substrate used was o-phenylenediamine
dihydrochloride (OPD; 2.5 mg/ml in 0.05 M citric acid, 0.1 M Na2HPO4, pH 5.0,
containing 0.03% (v/v) H2O2).

Native gel electrophoresis and blotting
Solutions containing either -lactalbumin (at 5 mg/ml), clusterin (at 1 mg/ml) or
mixtures of both (at the same respective concentrations) in 50 mM Na2HPO4, pH 7.0,
were incubated for 5 h at 37 oC with or without the addition of 20 mM DTT. In
addition, solutions containing -lactalbumin derivatives (at 0.67 mg/ml) or mixtures
of these derivatives and clusterin (both at 0.67 mg/ml) in 50 mM Na2HPO4, pH 7.0,
were incubated (without DTT) for 5 h at 37 oC. Precipitated protein was then
removed by centrifugation for 1 min at 10,000 rpm in a benchtop microfuge. 2 l of
loading buffer (0.01 % bromophenol blue, 20% (v/v) glycerol) was added to aliquots
of the supernatant in each case (containing 10 g of total protein) before loading on to
1% (w/v) agarose gels. Proteins were electrophoresed at 60 V for approximately 3 h
using 40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.0 as running buffer (the
structures of the various forms of -lactalbumin tested are not affected by EDTA).
Proteins were subsequently transferred to polyvinylidine difluoride membrane (MSI,
Westborough, MA, USA) by capillary transfer. The membranes were stained with
SuperStain (Pierce, Rockford, IL, USA) for approximately 5 min, destained (in 45%
(v/v) methanol, 10% (v/v) glacial acetic acid) for approximately 20 min, and then
scanned using a BioRad GS670 Imaging Densitometer.

NMR spectroscopy
Real-time one-dimensional 1H NMR spectra were acquired at 500 MHz on a Varian
Inova-500 NMR spectrometer. A sweep width of 5500 Hz was used over 9000 data
points with an acquisition time of 0.82 s per scan and a delay between scans of 1.0 s.
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Sixteen scans were acquired per spectrum which, along with two dummy scans, gave
a total time between successive spectra of approximately 33 s. Successive spectra
were acquired following the addition of 30 l of a 0.4 M solution of d10-DTT to 0.6
ml of 50 mM phosphate, 0.1 M NaCl, in D2O, pH 7.2 containing 3.0 mg/ml lactalbumin in the absence or presence of 0.7 mg/ml clusterin. Under the latter
conditions, the precipitation from solution of reduced -lactalbumin was completely
prevented by the formation of a solubilised, high-molecular-mass clusterin-lactalbumin complex [7]. An exponential line broadening of 3 Hz was applied to all
NMR spectra prior to Fourier transformation.
The effect of clusterin on slow versus rapid stress-induced precipitation of crystallin and lysozyme
The effects of clusterin on the slow precipitation from solution of -crystallin were
determined by heating -crystallin (at 1 mg/ml in 50 mM Na2HPO4, pH 7.0) at 60 oC
with or without 50 g/ml clusterin. Similar experiments were conducted in which
lysozyme (250 g/ml) was incubated at 42 oC in the same buffer as above containing
20 mM DTT, with or without 400 g/ml clusterin. The extent of protein precipitation
in each case was measured as turbidity (light scattering) at 360 nm using a model
8453 diode-array spectrophotometer (Hewlett-Packard GMBH, Germany). We have
shown before that control proteins (eg ovalbumin) do not inhibit protein precipitation
under these conditions [7]. In other experiments, the effects of clusterin on the rapid
precipitation of the same two proteins was determined; in these cases, for each target
protein, the mass ratio of clusterin:target was maintained at the same level as in the
experiments

measuring

slow

precipitation

(-crystallin:clusterin

=

20:1.0,

lysozyme:clusterin = 1.0:1.6). -Crystallin (300 g) was incubated for 20 min in 20 l
of denaturing buffer (50 mM Na2HPO4, pH 7.0, 6 M guanidine hydrochloride
(GuHCl)). This solution was added to 10 l of PBS containing 15 g of clusterin or
one of two control proteins (BSA or ovotransferrin) before, over approximately 1
min, successively adding 10-20 l aliquots of 50 mM Na2HPO4, pH 7.0, to effect
rapid protein precipitation. Similarly, 3 mg of lysozyme was incubated for 20 min in
30 l of denaturing buffer before 1 l of this solution was added to 19 l of PBS
containing 160 g of either clusterin, BSA or ovotransferrin. These mixtures were
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then diluted 5-fold, over approximately 1 min, with subsequent additions of 10 l
aliquots of 50 mM Na2HPO4, pH 7.0, to give a final volume of 100 l. For both
proteins, the requirement for step-wise dilutions precluded kinetic analyses of the
same type as that performed in the slow precipitation experiments. Experiments
measuring rapid protein precipitation were performed in the wells of microplates and
the end-point turbidity (representing the final level of protein precipitation) measured
as light scattering at 360 nm with a Spectramax 250 microplate reader (Molecular
Devices, Sunnyvale, CA, USA).
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3. RESULTS

ELISA and native gel electrophoretic analyses of the interaction of clusterin with
various structural forms of -lactalbumin
In ELISA, only negligible (probably non-specific) binding of clusterin to stable,
intermediately folded or unfolded forms of -lactalbumin (see Table 1) or to the
native form of the protein was detected (Figure 1A). In contrast, clusterin bound
strongly to reduced -lactalbumin (Figure 1A), confirming our earlier report of this
interaction [7]. The inability of clusterin to bind to the other structural forms of lactalbumin tested suggested that it is unable to complex with these forms in solution.
This interpretation was confirmed by native gel electrophoretic analyses, in which
pre-incubation with clusterin had no effect on the electrophoretic mobility of native
-lactalbumin or its stable derivatives (Figure 1B). When clusterin was co-incubated
with -lactalbumin prior to electrophoresis, two discrete bands corresponding to each
of the individual proteins were detected (Figure 1B, lane 5). However, when these
proteins were co-incubated with DTT under similar conditions, very much less
protein was detected in the bands corresponding to the individual proteins and a
single protein band of unique electrophoretic mobility, representing a clusterin-lactalbumin complex [7], was detected (Figure 1B, compare lanes 5 and 6). In a
previous study [7], reduced -lactalbumin was prepared in the same manner as this
study. The precipitation of reduced -lactalbumin was prevented by the presence of a
sufficient quantity of clusterin which resulted in the formation of a solubilized, high
molecular mass -lactalbumin-clusterin complex, detected by size exclusion
chromatography. SDS-PAGE was used to demonstrate that both proteins were present
in this complex [7].
Real-time 1H NMR analysis of the interaction between clusterin and reduced lactalbumin
Real-time 1H NMR spectra were acquired of reduced -lactalbumin in the absence
and presence of sufficient clusterin to prevent the precipitation of reduced lactalbumin (a 4.3:1.0 w:w ratio of -lactalbumin:clusterin; [7]). Figures 2A & B
show the aromatic region of selected NMR spectra of -lactalbumin without clusterin
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or in the presence of clusterin at various times after the addition of DTT. Being a
structured protein, -lactalbumin has a well-dispersed NMR spectrum, as is apparent
from the spectrum acquired prior to the addition of DTT (at 0 s; Figure 2A). After the
addition of DTT, successive spectra reflect the loss in structure of -lactalbumin as
its four disulphide bonds were sequentially reduced (Figure 2A). The hyper-reactive
disulphide bond between Cys6 and Cys120 is reduced very quickly (< 1 s) whereas
the remaining disulphide bonds are reduced over a much longer timeframe [14]. In
the absence of clusterin, as disulphide bond reduction occurred, the spectra changed
from (i) the resolved NMR spectrum of the native species (at 0 s), to (ii) a broad
spectrum with some dispersion, reflecting a partly folded intermediate containing
most secondary and some tertiary structure (I1, e.g. at 384 s), to (iii) a broad spectrum
lacking dispersion (I2, e.g. at 639 s), produced by an intermediate that has some
secondary structure but that lacks any tertiary structure (Figure 2A). The broadness of
both spectra reflects the dynamic nature of these intermediates that have
indeterminate conformation. The spectrum of I2 has strong similarities to that of the
partly folded intermediate of -lactalbumin observed at pH 2, the so-called molten
globule “A-state” [10]. With time, this spectrum was lost as reduced -lactalbumin
aggregated and precipitated.
Spectra from the I2 state of -lactalbumin were completely lost after ~ 1,700 s in the
absence of clusterin but, in the presence of clusterin, were still present 5400 s after
the addition of DTT (Figure 2B). This suggests that clusterin stabilises the I2 state of
-lactalbumin. Other than this difference, the real-time NMR spectra acquired

following the addition of DTT to -lactalbumin, either in the absence or presence of
clusterin, were generally similar in form (compare Figures 2A and 2B). The
concentration of clusterin used was too small to give rise to significant resonances in
the NMR spectrum. As for spectra acquired in the absence of clusterin, in the
presence of clusterin the spectrum from the I2 state of -lactalbumin was gradually
lost (Figure 2B). However, in this case, the loss of resonances was not due to the
protein precipitating but very probably arose because, under these conditions, lactalbumin is known to complex with clusterin to produce species of large molecular
mass [7] that would tumble slowly and give rise to very broad NMR spectra.
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The resonance at 6.8 ppm in the spectrum of the I2 form arises from the (3,5) aromatic
protons of the tyrosine residues of reduced -lactalbumin and is relatively isolated
from the broad envelope of other aromatic resonances (Figures 2A & B) [10,11].
Conveniently, native -lactalbumin does not have a significant resonance at this
chemical shift. Therefore, monitoring its intensity with time following addition of
DTT provides a means of following the buildup and decay of this state without
complications from resonance(s) arising from the native state of -lactalbumin.
Figure 2C shows a plot of the intensity of this resonance versus time after addition of
DTT for -lactalbumin in the absence and presence of clusterin. In both cases, the
resonance intensity built up rapidly to a maximum at ~ 380 s, indicating that clusterin
had no significant effect on the buildup of signal from the I2 state. Mass spectrometric
and stopped flow UV studies have shown that the maximum NMR resonance
intensity from the I2 state of -lactalbumin occurs when all four of its disulphide
bonds are reduced (J.A. Carver, R.A. Lindner, C. Lyon, D. Canet, H. Hernandez,
C.M. Dobson and C. Redfield, submitted for publication). Therefore, the data indicate
that clusterin does not significantly affect the rate of reduction of disulphide bonds in
-lactalbumin. After maximum resonance intensity was reached, the signal decayed
as I2 either (i) aggregated (in the absence of clusterin), or (ii) complexed with
clusterin (Figure 2C). As a means to compare the rates of decay of the 6.8 ppm
resonance for -lactalbumin, the equation for a first–order process was fitted to the
data shown in these figures. The resonance intensity decayed with time with apparent
first-order rate constants of, in the absence of clusterin, (1.81 ± 0.09) x 10-3 s-1 and, in
the presence of clusterin, (5.07 ± 0.13) x 10-4 s-1. Thus, under the conditions
described, clusterin approximately tripled the lifetime of the I2 state of -lactalbumin,
before complexing with it.

Analysis of the interaction of clusterin with slowly and rapidly precipitating
forms of -crystallin and lysozyme
-Crystallin, a major lens protein, slowly aggregates and precipitates when exposed to
elevated temperature [18]. Under the conditions tested (mass ratios of crystallin:clusterin = 20:1.0, and lysozyme:clusterin = 1.0:1.6), clusterin significantly
inhibited the slow precipitation of (i) -crystallin, induced by heating at 60 oC (Figure
3A), and (ii) lysozyme, induced by reduction at 42 oC (Figure 3B). Higher ratios of
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clusterin:target gave dose-dependent increases in the inhibition of precipitation of
either -crystallin or lysozyme (data not shown). When either -crystallin or lysozyme
is unfolded in 6 M GuHCl and then diluted into phosphate buffer, they rapidly
precipitate from solution. Using the same mass ratios of clusterin:target as in the
experiments measuring slow protein precipitation, clusterin had no significant effect
on the rapid precipitation of either -crystallin or lysozyme (Figures 3C and 3D).
Furthermore, even when the clusterin:target ratios were doubled, clusterin still failed
to inhibit the rapid precipitation of either protein (data not shown).
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4. DISCUSSION
Clusterin is a heterodimer comprised of  and  subunits linked by five disulphide
bonds that adopts an ill-defined heterogeneous aggregation state in aqueous solution.
Size exclusion chromatographic analysis indicates that DTT does not cause physical
dissociation of the  and  chains of clusterin [7]. Furthermore, the native gel
electrophoretic mobilities for unreduced and reduced clusterin (lanes 1 and 2 in Fig.
1B) are essentially identical, indicating that reduction does not induce any gross
changes in clusterin structure. Furthermore, reduction does not abrogate the
chaperone action of clusterin with a variety of target proteins [7,9]. Thus, reduced
clusterin is a functionally active protein.

From the results presented in Figure 1, it is apparent that clusterin does not bind to (i)
native -lactalbumin, (ii) its stable, monomeric, partly structured derivatives, or (iii)
the fully unfolded form of -lactalbumin. Previously, we also demonstrated that crystallin did not interact with these states of -lactalbumin [10]. However, clusterin
does bind to the reduced (stressed) form of the protein (Figure 1, and [7]). CD spectra
of reduced -lactalbumin show that it has some secondary structure but very little, if
any, tertiary structure (i.e. it is I2-like) [16]; this form slowly aggregates and
precipitates [7,10]. R-cam--lactalbumin also has an I2-like structure (Table 1) but,
unlike reduced -lactalbumin, is stable in solution as a monomeric species and does
not interact with clusterin. Clearly, the marked variation between the two lactalbumin species in their affinity for clusterin cannot be explained on the basis of
gross differences in structure. However, there must be subtle structural differences
which, in the case of reduced -lactalbumin, mean a greater exposure of
hydrophobicity to solution and a consequent tendency for it to undergo large-scale,
ill-defined aggregation [21]. Clusterin exists as a heterogeneous aggregate and
undergoes subunit exchange [22], a process similar to that undergone by reduced lactalbumin monomers which are continuously exchanging during their aggregation
to form species of a very broad mass range [21]. Thus, the similar dynamic and
heterogeneously aggregated nature of clusterin and reduced -lactalbumin may
facilitate their mutual incorporation into a complex during chaperone interaction.
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There are two phases to the interaction between -crystallin and the I2 state of
reduced -lactalbumin. Firstly, I2 is significantly stabilised and aggregation is
prevented, probably via transient interactions between the monomeric I2 state and crystallin. Secondly, I2 stably binds to -crystallin to form a complex of large mass
[10,11]. ther mammalian sHsps and plant sHsps behave in the same manner during
their interaction with reduced -lactalbumin [10,11, J.A. Carver, R.A. Lindner, M.
Gaestel, E. Basha, and E. Vierling, unpublished results]. Our results suggest that
clusterin interacts with the I2 state of -lactalbumin by a similar two-stage
mechanism. Firstly, real time NMR analysis showed that, during reductive stress,
clusterin extended the lifetime of the I2 state of -lactalbumin about three-fold (Figure
2C). This indicates that clusterin stabilised the non-aggregated (probably monomeric)
form of this intermediate. Secondly, the demonstration that clusterin forms a highmolecular-mass complex with reduced -lactalbumin [7] suggests that it, like crystallin, preferentially complexes with an unstable, intermediately folded state of lactalbumin. Furthermore, the progressive loss of the NMR spectrum of the I2 state of
-lactalbumin during reduction in the presence of clusterin is consistent with the

formation of a high-molecular-mass -lactalbumin-clusterin complex. A broad range
of other target proteins that have been stressed by either reduction or heating also
form complexes with clusterin [7,9].
The aggregation and precipitation of reduced -lactalbumin occurs relatively slowly.
The ability of clusterin to interact efficiently with this form of -lactalbumin and
prevent its precipitation suggested that kinetic factors might be important in
regulating the efficiency of clusterin chaperone action. To examine this hypothesis,
we tested the relative ability of clusterin to inhibit (i) the slow precipitation of crystallin and lysozyme (induced by heat and reduction, respectively), versus (ii) the
rapid precipitation of the same proteins induced by dilution from denaturant. Under
both conditions, the proteins unfold to adopt partly structured intermediates.
Experimentally, it has been shown that under dilute conditions, the major -crystallin
subunit, B, and lysozyme both form partly folded intermediates in the presence of
denaturant and when diluted from denaturant [23,24]. B-crystallin at pH 2.0 and in
3M urea forms an intermediate that has an unfolded C-terminal domain and a folded
N-terminal domain [23]. When lysozyme is diluted from denaturant, an intermediate
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rapidly forms that has tyrosine residues, but not tryptophan residues, exposed to
solvent [24]. This intermediate then rearranges with a t1/2 of 350 ms to form the native
state in which the tyrosine residues become buried but two tryptophan residues
become exposed to solvent. It is likely that these intermediates of B-crystallin and
lysozyme resemble those present in our studies in which high concentrations of these
proteins were rapidly diluted from solutions containing denaturant, resulting in their
rapid aggregation and precipitation. The results herein demonstrate that clusterin
efficiently inhibits the slow precipitation of -crystallin and lysozyme induced by heat
or reduction, but is incapable of preventing the rapid precipitation of the same
proteins induced by dilution from denaturant (Figure 3). Thus, the findings support
the hypothesis that kinetic factors are important in the chaperone action of clusterin
and suggest that it is unable to efficiently inhibit rapid protein precipitation.

In contrast to GroEL [15,16], the sHsps have no affinity for stable, partly folded
intermediate states of -lactalbumin, or unstable intermediate states of proteins that
aggregate and precipitate very rapidly [10,18,26]. The sHsps only bind to long-lived,
intermediate states of proteins that slowly aggregate as they progress along their offfolding pathway [10,11]. Furthermore, unlike Hsp60 and Hsp70, sHsps do not affect
the rate of folding of proteins (e.g. -lactalbumin) when they progress via a series of
transient intermediates along a folding pathway from their unfolded to folded form
[18,26, J.A. Carver, R.A. Lindner, C. Lyon, D. Canet, H. Hernandez, C.M. Dobson
and C. Redfield, submitted for publication]. Collectively, our results suggest that
clusterin shares all of these features with the sHsps. Furthermore, for -lactalbumin,
our results indicate that during reductive stress, like -crystallin and other sHsps,
clusterin stabilises the I2 state of -lactalbumin. Figure 4 summarises the steps in the
chaperone action of clusterin with reduced -lactalbumin.

In conclusion, the above data support the hypothesis that clusterin does not interact in
a chaperone role with stable, non-aggregating intermediate states of proteins or those
that are present when proteins undergo very rapid aggregation and precipitation.
Furthermore, we recently demonstrated that clusterin does not affect the heat-induced
loss of activity of glutathione-S-transferase or alcohol dehydrogenase or, when acting
alone, promote the refolding of these proteins to regain function following the
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removal of heat stress [9]. Thus, it appears likely that clusterin does not interact with
proteins along their folding/unfolding pathway, a process that occurs relatively
rapidly. Instead, clusterin prefers slowly aggregating, long lived and precipitationbound intermediate states of proteins that are present on an irreversible, off-folding
pathway (Figure 4). Clusterin complexes to these and thereby prevents their
precipitation. Therefore, the efficiency of the chaperone action of clusterin, like that
of the sHsps [10,11,26], is dependent on both conformational and kinetic factors.

Clusterin expression is increased in diseases characterised by protein misfolding,
aggregation and precipitation, for example, in Alzheimer’s and Creutzfeldt-Jakob
diseases [27]. In these diseases, fibrous protein precipitates known as amyloid or
plaque slowly form in extracellular spaces [3]. It is believed that amyloid formation
occurs via the association of destabilised, intermediately folded states of proteins
[28]. The observations that clusterin is an extracellular chaperone [8] and that it
interacts with these forms of proteins (results presented here), suggest that it may
influence the development of amyloid diseases. Indeed, Oda et al. [29] demonstrated
that clusterin inhibited the formation of large insoluble fibrils resulting from the
aggregation of amyloid -peptide, the putative causative agent in Alzheimer’s
disease. However, the pathogenicity of the resultant mixture towards neuronal cells
was enhanced, suggesting that the smaller fibrils formed in the presence of clusterin
are the pathogenic species. Similar effects were reported for the interaction of sHsps
with the amyloid -peptide [30,31]. The association of clusterin with Alzheimer’s
plaques in vivo [27] may reflect the inability of clusterin to completely inhibit the
large-scale precipitation of amyloid -peptide under pathogenic conditions. To
examine the potential role of clusterin in amyloid diseases, we are currently testing its
interactions with amyloid-forming proteins.
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Table 1. Modifications and structural features of -lactalbumin derivatives
investigated for their interaction with clusterin.
-Lactalbumin
derivative
R-cam-lactalbumin

Modifications

Structural features

Four disulphide bonds
reduced and subsequently
blocked by carboxyamidation

Disordered conformation,
with some secondary
structure but no tertiary
structure [10,13,16] (I2-like)
Unfolded conformation
[13,15,18]

R-cm--lactalbumin Four disulphide bonds
reduced and subsequently
blocked by
carboxymethylation
Cys6-Cys120
selectively
3SS--lactalbumin
reduced in the presence of
EDTA and blocked by
carboxymethylation

apo--lactalbumin

Heated at 45 oC in the
presence of EDTA to remove
bound Ca2+

reduced lactalbumin

Reduced by incubation with
20 mM DTT at 37oC

Relatively folded
conformation with most
secondary and some tertiary
structure. Similar in
conformation to heated apo-lactalbumin [10,13,14,16]
(I1-like)
Ordered conformation with
most secondary structure and
some tertiary structure.
Similar in conformation to
3SS--lactalbumin [10,13,16]
(I1-like)
Similar to R-cam-lactalbumin (I2-like) with the
exception that, unlike R-cam-lactalbumin, this form is
unstable in solution and
slowly aggregates and
precipitate [16]
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FIGURE LEGENDS
Figure 1. (A) Binding of clusterin to derivatives of -lactalbumin in ELISA. Results
of ELISA testing the binding of clusterin to various structural forms of -lactalbumin.
As controls, ELISA plates were also coated with reduced (DTT-treated) lactalbumin to which clusterin binds [7]. The results shown are representative of
several independent experiments. In each case, the error bars shown are standard
errors (SE) of the mean of triplicate measurements. In some cases, the SE are too
small to be visible. (B) Native gel electrophoresis of mixtures of clusterin and various
forms of -lactalbumin. Clusterin, or mixtures of clusterin with various forms of lactalbumin, were stressed as described in the Experimental section or left untreated
before subjecting the proteins to native gel electrophoresis. The image shows a native
gel following electrophoresis and protein staining. The key to the right of the image
indicates the identity of proteins or protein mixtures loaded into each lane. The arrow
indicates, in lane 6, a band of unique electrophoretic mobility corresponding to a
clusterin--lactalbumin complex (see text). The results shown are representative of
three independent experiments. Note that there are no protein bands visible in lane 4
because reduced -lactalbumin precipitates from solution.
Figure 2. Real-time 1H NMR spectroscopy and kinetics of the reduction of lactalbumin in the absence and presence of clusterin.
Aromatic region of the 1H NMR spectra of -lactalbumin at the times indicated after
the

addition

of

DTT.

(A)

-Lactalbumin

only;

(B)

4.3:1.0

w:w

-

lactalbumin:clusterin. Representative results are shown. (C) Plots showing the
resonance intensity of the -lactalbumin tyrosine (3,5) aromatic protons (at 6.8 ppm)
as a function of time during reduction; -Lactalbumin only (); 4.3:1.0 w:w lactalbumin:clusterin ().
Figure 3. The effect of clusterin on the slow and rapid precipitation of -crystallin
and lysozyme
Slow precipitation: (A) -Crystallin (1 mg/ml in 50 mM Na2HPO4, pH 7.0) was
heated at 60 oC in the presence () or absence () of clusterin (50 g/ml). (B)
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Lysozyme (250 g/ml) was reduced at 42 oC with 20 mM DTT in the presence () or
absence () of clusterin (400 g/ml). The data points shown in (A) and (B) each
represent the mean of triplicate measurements; the SE of the means are too small to
be visible. Rapid precipitation: (C) 300 g of 6 M GuHCl-denatured -crystallin (see
Materials and Methods) was rapidly precipitated following a 10-fold dilution with 50
mM Na2HPO4 buffer, pH 7.0, in the presence of 15 g of either clusterin (solid bar),
BSA (shaded bar) or ovotransferrin (striped bar). (D) 100 g of 6 M GuHCldenatured lysozyme was rapidly precipitated following a 5-fold dilution with 50 mM
Na2HPO4 buffer, pH 7.0, in the presence of 160 g of either clusterin (solid bar),
BSA (shaded bar) or ovotransferrin (striped bar). In (A) to (D), protein precipitation
(turbidity) was measured as light scattering at 360 nm (A360). In (C) and (D), only end
point precipitation was measured and error bars shown are standard errors of the
mean of triplicate measurements in each case; none of the proteins added had a
significant effect on the extent of rapid precipitation of either -crystallin or lysozyme
(p>0.05, t-test). The results shown are representative of three independent
experiments.

Figure 4. A proposed mechanism for the chaperone interaction of clusterin with
reduced -lactalbumin.
I1 and I2 represent, respectively, more structured and less structured, partly folded
intermediates of -lactalbumin. Thus, I1 is characterised by having most secondary
structure in place and some elements of tertiary structure, whereas I2 has some
elements of secondary structure but little or no tertiary structure. Under reducing
conditions, the I2 species is long lived and is prone to entering the slow and
irreversible off-folding pathway leading to aggregation and precipitation. It is this
species that clusterin recognises, stabilises (probably via transient interactions with
the monomeric species), and eventually complexes with, to prevent precipitation of
-lactalbumin.
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